India Rejects J&J Plea to Extend Patent on Key Tuberculosis Drug, Drop in Prices Expected

The patent on the drug made India dependent on supplies from J&J. The latest decision will pave the way for generic versions in the local market, increasing access

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.